PEPTONIC medical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Anna Linton
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.004% |
Management average tenure | no data |
Board average tenure | 1.4yrs |
Recent management updates
Recent updates
CEO
Anna Linton (53 yo)
less than a year
Tenure
Ms. Anna Linton is Chief Executive Officer of Pharmiva AB (publ) from August 2022. She is Chief Executive Officer since February 06, 2024 at PEPTONIC medical AB (publ). She has several years of experience...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Director | 1.8yrs | SEK 117.00k | 0.76% € 226.6k | |
Chairman of the Board | 1.4yrs | SEK 229.00k | 4.08% € 1.2m | |
Director | less than a year | no data | 0.0083% € 2.5k | |
Board Member Lune Group Oy Ltd | no data | no data | no data | |
Director | no data | SEK 200.00k | 0.0080% € 2.4k |
1.4yrs
Average Tenure
53.5yo
Average Age
Experienced Board: 28L's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.